Ayer Capital Management Shows New 5.51% Stake in Peregrine Pharmaceuticals (PPHM)
Tweet Send to a FriendGet Alerts PPHM Hot Sheet
Up)
Trade PPHM Now!
In a 13G filing on Peregrine Pharmaceuticals (NASDAQ: PPHM), hedge fund Ayer Capital Management disclosed a 5.51%, or 3,743,030 share, stake in the company. The firm held calls options representing 2 million shares at the end of the latest quarter ending September 30, 2012.
For more notable holders of PEREGRINE PHARMA stock click here. For more information on Ayer Capital Management click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more notable holders of PEREGRINE PHARMA stock click here. For more information on Ayer Capital Management click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Kyle Bass 13G Shows 9.7% Stake in Dex Media (DXM)
- Elliott Management: Dividend, Buyback are 'Positive Steps' for NetApp (NTAP)
- Headline, Performance Risk Pressure SAC Capital; May Close to New Investors
Create E-mail Alert Related Categories
13Gs, Hedge FundsRelated Entities
Hedge Funds, 13G, Ayer Capital Management
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
